ILIAS Biologics Inc.
Dr. Park brings deep expertise in drug development and regulatory affairs. He served as a reviewer at the US FDA where he worked for over 11 years in charge of reviewing BLA/NDA and conducting scientific research for evaluation of the manufacturing process and product quality assessment for biopharmaceutical products. Before joining the FDA, Dr. Park worked for Alpha-Beta Technology, Inc. and US Department of Defense (DoD). He joined ILIAS from Helixmith, where he was Senior Vice President of Licensing and Regulatory Affairs.
Dr. Park received his bachelor’s degree in chemical engineering from Yonsei University and earned his Ph.D. in biochemical engineering from Worcester Polytechnic Institute in Massachusetts, USA.
This person is not in any offices
ILIAS Biologics Inc.
2 followers
At ILIAS Biologics, they dedicate themselves to the development of paradigm-shifting advances in human medicine. Their platform technology, EXPLOR, makes it possible to load large therapeutic molecules into exosomes, and they are actively developing various therapeutic exosomes, Exo-Targets, as potential treatments for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.